The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications.
about
Secukinumab: A New Treatment Option for Psoriatic ArthritisTh17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitisTh17 Pathway As a Target for Multipotent Stromal Cell Therapy in Dogs: Implications for Translational Research.Therapeutic Effects of Erythroid Differentiation Regulator 1 on Imiquimod-Induced Psoriasis-Like Skin Inflammation.Safety and Efficacy of Brodalumab for Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Meta-Analysis.Brodalumab for the treatment of psoriasis.The role of IL-17 in the treatment of psoriatic arthritis.Overexpression and potential roles of NRIP1 in psoriasis.Ixekizumab: an anti- IL-17A monoclonal antibody for the treatment of psoriatic arthritis.Pharmacogenetics and Pharmacogenomics in Moderate-to-Severe Psoriasis.Unmet Needs in Axial Spondyloarthritis.Genetic and experimental evidence for the involvement of the CD6 lymphocyte receptor in psoriasis.Immunophenotyping of T cells in the peripheral circulation in psoriasis.Psoriasis and inflammatory bowel disease: links and risks.Transcription Factor Retinoid-Related Orphan Receptor γt: A Promising Target for the Treatment of Psoriasis.The potential role of Th17 lymphocytes in patients with psoriasis.
P2860
Q28066204-4D849F91-1A46-414E-940E-38B0841DD423Q28067738-5F22228B-8B13-40E8-9753-866E97294BBAQ35922408-7980719E-7920-4BC4-8BCF-54197C0F7A89Q36667189-C3E8EE14-0D59-40E7-AF45-4EFE6CCBC8CDQ38961129-9BB09C76-C351-4052-BF73-0BF960CBBB30Q38975719-845D0322-08B1-4AB4-B495-D07F8E33924CQ39293096-6990E638-9620-4A4D-96D0-30F92D11506AQ39318754-2239F823-6BEF-48FF-A048-6D9EC0B47761Q47696280-91BB221B-7085-47D1-B9AB-B278021C424DQ47786696-03ABFB54-D1D3-4C4D-97D7-432D83D6A372Q48287506-C9B9C6D9-DE3A-41AF-B38F-7218C95AF2FAQ49962988-8DFBAD21-AFDD-4806-890C-2760D1157568Q51603409-3453A95C-B978-4E77-A4A2-4D4F7074DC2CQ52859380-887FCAF8-7864-45AF-9BAD-90FE20F587C3Q55031102-B61810C1-DC15-4637-A4E6-7407BE14880EQ55077651-AD330CEE-C2A8-4D40-83AA-001DF9E440A1
P2860
The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications.
@ast
The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications.
@en
type
label
The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications.
@ast
The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications.
@en
prefLabel
The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications.
@ast
The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications.
@en
P2860
P50
P1476
The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications.
@en
P2093
Beatrice Marinoni
P2860
P2888
P356
10.1007/S13317-013-0057-4
P577
2014-01-22T00:00:00Z